Existing product
Scientific reasoning
SinaPilot
Source-grounded research, structured summaries and evidence analysis for scientific teams.
- PubMed & Europe PMC
- Evidence synthesis
- Source-linked Q&A
INVESTOR RELATIONS / DEEPTECH THESIS
Invest in the evidence behind intelligence.
A focused AI infrastructure venture: existing scientific and visual technology assets, a shared verification research programme and an execution-led founder.
Request an introductionTHE INVESTMENT THESIS
AI adoption creates a verification problem.
As agents enter consequential workflows, observability alone cannot establish that an answer or action is supported by evidence.
NEXORYN’s hypothesis is that domain-specific evaluation, provenance and multimodal checks can become a reusable infrastructure layer. The thesis must be tested through benchmarks and enterprise pilots.
ASSETS / WHAT EXISTS TODAY
A starting point beyond the thesis.
Existing product
Visual web intelligence
Snapshot Site
Rendered web capture and visual analysis infrastructure for developers and AI agents.
- Screenshot & PDF
- Visual comparison
- MCP, CLI & SDKs
Proposed R&D
Shared verification infrastructure
NEXORYN VERIFY
A proposed common layer to connect agent outputs with evidence, evaluation and review.
- Evidence & provenance
- Evaluation protocols
- Human review
Evidence status
Product usage has been reported. Verified traction is not published yet.
The founder’s materials describe Snapshot Site API usage, subscriptions and historical revenue. Underlying statements have not been independently checked for this site. No ARR, customer count, partnership or financial projection is asserted. Request supporting records for due diligence.
DIFFERENTIATION / TO BE PROVEN
A moat built through research, not a model wrapper.
Domain evaluation
Expert-reviewed benchmarks and failure datasets could create measurable differentiation. Ownership and performance remain to be established.
Evidence representation
A shared graph of sources, claims and contradictions could make results reproducible and auditable.
Cross-modal checks
Scientific evidence and rendered web observations provide complementary verification contexts.
RESEARCH ROADMAP / 2027–2028
Milestones that reduce uncertainty.
Indicative research objectives, dependent on financing and pilot results. No completed patents, certifications or research partnerships are claimed.
- 01
Foundation
Map reusable technology and IP. Establish evaluation baselines and validate buyer needs.
- 02
Research prototypes
Prototype evidence graphs and visual action checks with prospective design partners.
- 03
Pilot validation
Test a shared API in bounded workflows. Compare results against expert review and failure cases.
- 04
Industrialisation
Advance reliability, security and repeatable enterprise delivery when pilot evidence supports it.
BUSINESS MODEL HYPOTHESES
Validate value. Then scale distribution.
- Product subscriptions & API usage
SinaPilot and Snapshot Site are the entry points for repeatable product demand.
- Enterprise pilots & integrations
Paid pilots, dedicated integrations and support are hypotheses to test with buyers.
- Verification infrastructure
Usage-based VERIFY APIs and enterprise licences are proposed, not current platform revenue.
Indicative cash funding objective
€400k
Fund talent, research and market evidence.
Founder’s 2027–2028 strategy objective. Round structure, timing, valuation and terms remain to be defined.
60% R&D & product20% Go-to-market10% IP & validation10% Operations
Indicative allocation from supplied branding material. Cloud and programme credits described in the strategy are in-kind support, not cash or investment. Their value and availability require confirmation.
FOUNDER / EXECUTION
Built by an operator.
Rabii Jemaiel
Founder & CTO
15+ years of experience across cloud, AI and production platforms, including 9 years of team leadership, as described in the supplied founder profile. Founder of SinaPilot and Snapshot Site.
Meet the founderInvestment involves technical and market risk. This page is an introduction to the venture, not an offer of securities.